Alemtuzumab Intravenous and Bendroflumethiazide and nadolol
Determining the interaction of Alemtuzumab Intravenous and Bendroflumethiazide and nadolol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: bendroflumethiazide / nadolol
Brand name: Corzide 40/5, Corzide 80/5, Corzide
Synonyms: Nadolol and Bendroflumethiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-BeneFIX
- Alemtuzumab Intravenous-Benefix Intravenous
- Alemtuzumab Intravenous-Benemid
- Alemtuzumab Intravenous-BENGAY Ultra
- Alemtuzumab Intravenous-Benicar
- Alemtuzumab Intravenous-Benicar HCT
- Bendroflumethiazide and nadolol-Alenaze-D
- Bendroflumethiazide and nadolol-Alendronate
- Bendroflumethiazide and nadolol-Alendronate and cholecalciferol
- Bendroflumethiazide and nadolol-Alendronate Effervescent Tablets
- Bendroflumethiazide and nadolol-Alendronate Oral Solution
- Bendroflumethiazide and nadolol-Alendronate Sodium